Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'a 317491 sodium salt hydrate'

Search results for: 'a 317491 sodium salt hydrate'

Items 31-40 of 42

Page
per page
  1. PF-00562271
    A8320 PF-00562271
    Target: FAK|Pyk2
    Summary: FAK/Pyk2 inhibitor,potent and ATP-competitive
      insoluble in EtOH; insoluble in H2O; ≥11.1 mg/mL
  2. PF-562271 HCl
    A8345 PF-562271 HCl
    Target: FAK|Pyk2
    Summary: FAK/Pyk2 inhibitor
      ≥26.35 mg/mL
  3. Phenformin HCl
    B1373 Phenformin HCl
     1 Citation
    Target: AMPK
    Summary: biguanidine drug with anti-diabetic activity
      ≥12.1 mg/mL
  4. Bleomycin Sulfate
    A8331 Bleomycin Sulfate
     1 Citation
    Summary: Chemotherapy agent, induces DNA strand break
      ≥125 mg/mL
  5. A-803467
    B2277 A-803467
    Target: Voltage-gated Sodium (NaV) Channels
    Summary: NaV1.8 channel blocker,potent and selective
      insoluble in H2O; ≥13.95 mg/mL
  6. Lidocaine
    A1450 Lidocaine
    Target: Histamine H1 Receptors
    Summary: Anasthetic and class Ib antiarrhythmic agent
      insoluble in H2O; ≥11.72 mg/mL
  7. Sitagliptin phosphate monohydrate
    A4036 Sitagliptin phosphate monohydrate
     5 Citation
    Target: DPP-4
    Summary: Potent DPP-4 inhibitor
      ≥23.8 mg/mL
  8. Rosiglitazone maleate
    A4302 Rosiglitazone maleate
    Target: Insulin and Insulin-like Receptors
    Summary: PPARγ agonist,high-affinity and selective,potent insulin sensitizer
      ≥23.7 mg/mL
  9. Istaroxime
    A3507 Istaroxime
     1 Citation
    Target: Na /K ATPases
    Summary: Na+/K+ ATPase inhibitor
      Soluble in H2O
  10. Canagliflozin
    A8333 Canagliflozin
     1 Citation
    Target: SGLT
    Summary: SGLT2 inhibitor,potent and selective
      ≥22.25 mg/mL

Items 31-40 of 42

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 36item
  2. Probes & Dyes 1 item
Reversibility
  1. Reversible 4item
  2. Irreversible 2item
Target
  1. Caspases 1 item
  2. Cathepsins 1 item
  3. Histone Deacetylases (HDACs) 2item
  4. CXCR 1 item
  5. MMP 1 item
  6. P-glycoprotein (P-gp) 1 item
  7. PLK 1 item
  8. Voltage-gated Sodium (NaV) Channels 3item
  9. Deubiquitinating enzymes (DUBs) 1 item
  10. PP1 1 item
  11. PP2A 1 item
  12. Endothelin receptors 1 item
  13. FAK 2item
  14. HSP90 1 item
  15. AMPK 1 item
  16. Topoisomerases 1 item
  17. Cytochrome P450 (CYP450) 1 item
  18. ErbB 1 item
  19. DNA Methyltransferases 1 item
  20. Epac 1 item
  21. HMG-CoA Reductases 1 item
  22. Calpains 1 item
  23. CysLT1 1 item
  24. SGLT 1 item
  25. Trypsins 1 item
  26. Pyk2 2item
  27. Insulin and Insulin-like Receptors 1 item
  28. BCPCF efflux 1 item
  29. ROS and Other Gaseous Donors 1 item
  30. Histamine H1 Receptors 1 item
  31. Na /K ATPases 1 item
  32. Ionophores 1 item
  33. Bone resorption 1 item
  34. Aldosterone receptor 1 item
  35. NAE 1 item
  36. DPP-4 1 item
  37. PP4 1 item
  38. Elastases 1 item
Reported Experiments
  1. Animal Experiments 40item
  2. Cell Experiments 28item
Related Disease
  1. Abscesses And Esophageal Candidiasis 1 item
  2. Acute Disseminated Candidiasis 1 item
  3. Acute Lung Injury 1 item
  4. Acute Myelogenous Leukemia 1 item
  5. Breast Cancer 5item
  6. Cancer 20item
  7. Candida Peritonitis 1 item
  8. Candidemia 1 item
  9. Colon Cancer 1 item
  10. Colorectal Cancer 2item
  11. Fungal Infection 1 item
  12. Heart Failure 1 item
  13. Hepatocellular Carcinoma 2item
  14. HIV Infections 1 item
  15. Lung Cancer 3item
  16. Lymphoma 1 item
  17. Melanoma 1 item
  18. Multiple Myeloma 1 item
  19. Non-small Cell Lung Cancer 2item
  20. Osteoporosis 1 item
  21. Pancreatic Cancer 4item
  22. Prostate Cancer 2item
  23. Type 2 Diabetes 3item